Showing 241 - 250 of 130,277
Persistent link: https://www.econbiz.de/10009775884
. -- pharmaceutical innovation ; regulation ; adoption ; duration analysis …
Persistent link: https://www.econbiz.de/10009127576
Problem Definition: Healthcare expenditures are increasing worldwide, and spending on pharmaceutical drugs is a major contributor to this trend. Many countries are responding by implementing external reference pricing (ERP) to contain drug prices, which is a commonly used policy by countries...
Persistent link: https://www.econbiz.de/10013314648
Persistent link: https://www.econbiz.de/10012391533
This book presents an extensive study on the effectiveness of recent regulations on pharmaceutical prices in India, exploring the weaknesses in the design and implementation of pharmaceutical price controls and investigating what can be done to fix the broken system. In addition, it examines the...
Persistent link: https://www.econbiz.de/10012396837
This paper examines aspects of the policy environment and market characteristics of the Swiss pharmaceutical sector, and assesses the degree to which Switzerland has achieved certain policy goals. In Switzerland, pharmaceutical spending has not been growing faster than health expenditure as a...
Persistent link: https://www.econbiz.de/10012445049
This paper describes and assesses pharmaceutical pricing and reimbursement policies in Canada, considering them in the context of the broader policy and market environment in which they operate, and investigating their role in contributing to Canada’s achievements in meeting a range of...
Persistent link: https://www.econbiz.de/10012445168
price regulation. It notes that retail prices for pharmaceuticals are relatively high, although proximity to the United … question the sustainability of financing pharmaceuticals in Mexico. It also contributes to greater inequality, although a new … unintended side-effect of the loss of low cost, non-bioequivalent drugs may be higher average prices for pharmaceuticals. …
Persistent link: https://www.econbiz.de/10012446729
to low mark-ups in the distribution chain and no VAT for prescribed medicines, Sweden's public prices for pharmaceuticals … national income to pharmaceuticals. What limited evidence exists tends to suggest that relatively low pharmaceutical … reimbursement status of new pharmaceuticals and mandatory substitution of the lowest-cost generic alternative. The use of cost …
Persistent link: https://www.econbiz.de/10012447076
branded pharmaceuticals. We then present a theoretical framework for the pricing of branded pharmaceuticals, without and then …
Persistent link: https://www.econbiz.de/10012462361